title: Rebif offers another option for treating multiple sclerosis.
authors.affiliation: Division of Pharmacy Practice and Science College of Pharmacy, University of Kentucky, Lexington, USA.
authors.forename: Melody
authors.initials: M
authors.lastname: Ryan
mesh_terms: D000276:Adjuvants, Immunologic / Q000191:economics / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007279:Injections, Subcutaneous; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000191:economics / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*
chemical_list: D000276:Adjuvants, Immunologic; D016899:Interferon-beta; D000068556:Interferon beta-1a